SCHEMBL474369

SCHEMBL474369

Cc1ccc2oc(-c3ccc(N)cc3)nc2c1

nearest known ligand 0.82

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
RAB9A P51151 15/20 0.82
NPC1 O15118 14/20 0.82
KDM4E B2RXH2 10/20 0.82
ALDH1A1 P00352 10/20 0.82
SMN1; SMN2 Q16637 9/20 0.82
MAPT P10636 8/20 0.82
HSD17B10 Q99714 6/20 0.82
TP53 P04637 5/20 0.82
NFKB1 P19838 5/20 0.82
NFKB2 Q00653 5/20 0.82
RELA Q04206 5/20 0.82
L3MBTL1 Q9Y468 2/20 0.82
HPGD P15428 8/20 0.81
GFER P55789 2/20 0.76
RXFP1 Q9HBX9 2/20 0.76
CASP3 P42574 3/20 0.71
SENP8 Q96LD8 2/20 0.71
SENP7 Q9BQF6 2/20 0.71
SENP6 Q9GZR1 2/20 0.71
POLB P06746 1/20 0.71

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31154077 1.00 RAB9A (0.82) RAB9ANPC1KDM4EALDH1A1SMN1; SMN2
SCHEMBL14947173 0.92 ALDH1A1 (0.96) RAB9ANPC1KDM4EALDH1A1SMN1; SMN2
SCHEMBL2245029 0.90 RAB9A (1.00) RAB9ANPC1KDM4EALDH1A1SMN1; SMN2
SCHEMBL3288386 0.90 ALDH1A1 (1.00) RAB9ANPC1KDM4EALDH1A1SMN1; SMN2
SCHEMBL15047797 0.90 ALDH1A1 (0.93) RAB9ANPC1KDM4EALDH1A1SMN1; SMN2
SCHEMBL2247430 0.87 NPC1 (0.77) RAB9ANPC1KDM4EALDH1A1SMN1; SMN2
SCHEMBL5654856 0.86 RAB9A (0.86) RAB9ANPC1KDM4EALDH1A1SMN1; SMN2
SCHEMBL29603993 0.86 RAB9A (0.86) RAB9ANPC1KDM4EALDH1A1SMN1; SMN2
SCHEMBL29404722 0.86 RAB9A (1.00) RAB9ANPC1KDM4EALDH1A1SMN1; SMN2
SCHEMBL1852701 0.86 RAB9A (1.00) RAB9ANPC1KDM4EALDH1A1SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 37 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20220017503-A1 TRIBENZAZOLE AMINE DERIVATIVE AND ORGANIC ELECTROLUMINESCENT DEVICE COMPRISING SAME LAPTO CO., LTD. (KR) 2022-01-20 US disclosed
CN-111620833-A Preparation method of 2-phenylbenzoxazole compound 青岛伯川特聚科技有限公司 2020-09-04 CN disclosed
EP-2112206-B1 Polymer Composition ROHM & HAAS (US) 2016-06-29 EP disclosed
EP-2166043-B1 Thickener composition and method for thickening aqueous systems ROHM & HAAS (US) 2016-04-27 EP disclosed
US-8330039-B2 Solar cell modules with poly(vinyl butyral) encapsulant comprising unsaturated heterocyclic compound E I DU PONT DE NEMOURS AND COMPANY (US) 2012-12-11 US disclosed
EP-2166044-B1 Thickened compositions and method for thickening aqueous polymer compositions ROHM & HAAS (US) 2012-02-01 EP disclosed
US-20110281980-A1 Thickener composition and method for thickening aqueous systems BOBSEIN BARRETT RICHARD (US) 2011-11-17 US disclosed
EP-2380208-A1 SOLAR CELL MODULES WITH POLY(VINYL BUTYRAL) ENCAPSULANT COMPRISING UNSATURATED HETEROCYCLIC COMPOUND E. I. du Pont de Nemours and Company (US) 2011-10-26 EP disclosed
US-8034869-B2 Thickened compositions and method for thickening aqueous polymer compositions ROHM AND HAAS COMPANY (US) 2011-10-11 US disclosed
US-7985795-B2 Thickener composition and method for thickening aqueous systems ROHM AND HAAS COMPANY (US) 2011-07-26 US disclosed
CN-1930121-A Substituted heteroaryl- and phenylsulfamoyl compounds PFIZER PROD INC (US) 2007-03-14 CN disclosed
US-20060258723-A1 Substituted Heteroaryl- and Phenylsulfamoyl Compounds PFIZER INC 2006-11-16 US disclosed
US-20050228015-A1 Substituted heteroaryl- and phenylsulfamoyl compounds PFIZER INC 2005-10-13 US disclosed
EP-0688830-B1 Azo compounds and polarizing films using the compounds MITSUI CHEMICALS INC (JP) 1998-11-18 EP disclosed
US-5698682-A HIGH HEAT RESISTANCE; EXCELLENT OPTICAL PROPERTIES; DICHROIC DYES MITSUI TOATSU CHEMICALS, INC. (JP) 1997-12-16 US disclosed
US-5639809-A AZO COMPOUND DISTRIBUTED IN POLYMER FILM; HEAT RESISTANCE MITSUI TOATSU CHEMICALS, INC. (JP) 1997-06-17 US disclosed
EP-0527704-B1 Dyestuffs, process for their preparation and the use thereof CIBA GEIGY AG (CH) 1996-08-28 EP disclosed
EP-0688830-A1 Azo compounds and polarizing films using the compounds MITSUI TOATSU CHEMICALS, Inc. (JP) 1995-12-27 EP disclosed
US-5302704-A For dyeing polyamide fibers; colorfastness CIBA-GEIGY CORPORATION (US) 1994-04-12 US disclosed
EP-0527704-A2 Dyestuffs, process for their preparation and the use thereof CIBA-GEIGY AG (CH) 1993-02-17 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050228015-A1 Substituted heteroaryl- and phenylsulfamoyl compounds PPARA, PPARG, PPARD RAB9A 2271/4885NPC1 59/4885KDM4E 3834/4885
US-20060258723-A1 Substituted Heteroaryl- and Phenylsulfamoyl Compounds PPARG, PPARA, PPARD RAB9A 2063/4885NPC1 74/4885KDM4E 3815/4885
US-20220017503-A1 TRIBENZAZOLE AMINE DERIVATIVE AND ORGANIC ELECTROLUMINESCENT DEVICE COMPRISING SAME CYP2E1, CYP1B1, ODC1 RAB9A 2949/4885NPC1 4030/4885KDM4E 1101/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.